HIV and Pregnancy: Transmission Risks and Prevention
Without intervention, mother-to-child transmission (MTCT) of HIV occurs in 15–45% of cases. With modern protocols, risk drops to <1%.
Transmission Timing
- In utero: Transplacental (late pregnancy).
- Intrapartum: Exposure to blood/secretions during delivery (highest risk).
- Postpartum: Breastfeeding (significant risk if not on ART).
Prevention Protocol (Perinatal Guidelines)
- Universal HIV testing in pregnancy (opt-out).
- Antiretroviral therapy (ART) for all pregnant women with HIV—start ASAP, continue lifelong.
- Viral load monitoring: Target <50 copies/mL by delivery.
- Delivery planning: Scheduled C-section at 38 weeks if VL >1,000 copies/mL or unknown.
- Neonatal prophylaxis: Zidovudine ± other ARVs for 2–6 weeks.
- Avoid breastfeeding in resource-rich settings (safe formula available). In resource-limited settings, exclusive breastfeeding + maternal ART is recommended.
Multidisciplinary care (OB, ID, pediatrics) optimizes outcomes.
HIV & AIDS - Related Articles
- HIV/AIDS Treatment for Children: Access & Antiretroviral Therapy
- Jim Nabors' Cause of Death: Debunking HIV Rumors
- HIV Testing: Why Routine Blood Tests Don't Detect HIV
- HIV and the Immune System: Understanding the Impact
- Runny Nose and HIV: No Direct Link
- Analgesics & NSAIDs: Understanding Pain Relief & Inflammation
- Understanding HIV Transmission in Men: Risks and Prevention
